Work

Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future

Year: 2014

Type: review

Source: Expert Review of Neurotherapeutics

DOI: 10.1586/14737175.2015.995637

Authors: Harald Hampel, Lon S Schneider, Ezio Giacobini, Miia Kivipelto, Shireen Sindi, Bruno Dubois, Karl Broich, Robert Nisticò, Paul S Aisen, Simone Lista

Institutions: Pitié-Salpêtrière Hospital, AXA Research Fund, Institut du Cerveau, Université Pierre-et-Marie-Curie, University of Southern California, University of Geneva, University Hospital of Geneva, Stockholm University, University of Eastern Finland, Karolinska Institutet, Federal Institute for Drugs and Medical Devices, Fondazione Santa Lucia, Sapienza University of Rome, University of California San Diego

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Aging

Awards: G104586243, G1627990026, A Phase 2 Trial of AAV-NGF Gene Delivery in Alzheimer's Disease, G453222670, Alzheimer's Disease Cooperative Study (ADCS), Alzheimer's Disease Neuroimaging Initiative, Alzheimer Disease Research Center, VITAMIN E TRIAL IN PERSONS WITH DOWN SYNDROME, G935954831

OpenAlex ID: W2029883685

FWCI: 1.327

Cites: 167

Cited by: 76

Related to: 10